Vitura Health Limited

ASX:VIT Stok Raporu

Piyasa değeri: AU$56.4m

Vitura Health Yönetim

Yönetim kriter kontrolleri 2/4

Vitura Health's CEO is Tom Howitt, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is A$438.54K, comprised of 89% salary and 11% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth A$117.60K. The average tenure of the management team and the board of directors is 1.4 years and 1.5 years respectively.

Anahtar bilgiler

Tom Howitt

İcra Kurulu Başkanı

AU$438.5k

Toplam tazminat

CEO maaş yüzdesi89.0%
CEO görev süresiless than a year
CEO sahipliği0.2%
Yönetim ortalama görev süresi1.4yrs
Yönetim Kurulu ortalama görev süresi1.5yrs

Son yönetim güncellemeleri

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21
Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Recent updates

There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Oct 17
There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Oct 13
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Sep 07
Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Aug 12
Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 12
Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Apr 25
The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27
Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Dec 13
Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21
Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Nov 01
Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Jul 18
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Sep 12
Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Sep 05
If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

CEO Tazminat Analizi

Tom Howitt'un ücretlendirmesi Vitura Health'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$439kAU$390k

AU$4m

Mar 31 2024n/an/a

AU$6m

Dec 31 2023n/an/a

AU$9m

Sep 30 2023n/an/a

AU$12m

Jun 30 2023AU$669kAU$320k

AU$14m

Mar 31 2023n/an/a

AU$12m

Dec 31 2022n/an/a

AU$10m

Sep 30 2022n/an/a

AU$8m

Jun 30 2022AU$818kAU$307k

AU$6m

Mar 31 2022n/an/a

AU$5m

Dec 31 2021n/an/a

AU$5m

Sep 30 2021n/an/a

AU$3m

Jun 30 2021AU$429kAU$307k

AU$1m

Mar 31 2021n/an/a

-AU$194k

Dec 31 2020n/an/a

-AU$2m

Sep 30 2020n/an/a

-AU$3m

Jun 30 2020AU$443kAU$307k

-AU$4m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019n/an/a

-AU$4m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019AU$354kAU$175k

-AU$3m

Tazminat ve Piyasa: Tom's total compensation ($USD287.47K) is about average for companies of similar size in the Australian market ($USD299.27K).

Tazminat ve Kazançlar: Tom's compensation has been consistent with company performance over the past year.

CEO

Tom Howitt (60 yo)

less than a year

Görev süresi

AU$438,538

Tazminat

Mr. Thomas Godfrey Howitt, also known as Tom, BCom, CA, FTIA, ACIS, AICPA, is Interim Chief Executive Officer of Vitura Health Limited (formerly known as Cronos Australia Limited) since April 22, 2024 and...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Thomas Howitt
Interim Chief Executive Officerless than a yearAU$438.54k0.21%
A$ 117.6k
Ben Cirillo
Interim Chief Financial Officerless than a yearAU$58.07k0.025%
A$ 13.8k
Ryan Tattle
Chief Revenue Officer1.8yrsAU$362.46k0.60%
A$ 338.2k
Nicola Swarbrick
Chief Operating Officerless than a yearVeri yokVeri yok
Stefan Schmidt
Chief Technology Officerless than a yearVeri yokVeri yok
Erin Leckie
Interim Head of Marketing3.4yrsVeri yokVeri yok
Deanna Johns
Head of People & Culture2.8yrsVeri yokVeri yok
Jeffrey Lerner
Head of Technology1.4yrsVeri yokVeri yok
Natalie Khoury
Head of Customer Experience1.5yrsVeri yokVeri yok

1.4yrs

Ortalama Görev Süresi

Deneyimli Yönetim: VIT's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Robert Iervasi
Independent Non-Executive Chairmanless than a yearAU$67.83k0.080%
A$ 45.0k
Guy Headley
Non-Executive Directorless than a yearAU$409.40k17.27%
A$ 9.7m
Marcia Ani Walker
Independent Non-Executive Director2.9yrsAU$71.92kVeri yok
Jenelle Frewen
Independent Non-Executive Director2.2yrsAU$55.50k0.033%
A$ 18.7k

1.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: VIT's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.